Imidazoline receptors, novel agents and therapeutic potential.
about
Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotectionFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansBrain stem adenosine receptors modulate centrally mediated hypotensive responses in conscious rats: A reviewHuman and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.Behavioral effects of the imidazoline I(2) receptor ligand BU99006 in ratsImidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors.Acute and chronic stress differentially regulate cyclin-dependent kinase 5 in mouse brain: implications to glucocorticoid actions and major depressionCR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Characterization of the hypothermic effects of imidazoline I₂ receptor agonists in ratsAgmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in MacrophagesEuglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidineDecrease of Obesity by Allantoin via Imidazoline I 1 -Receptor Activation in High Fat Diet-Fed Mice.Gender difference in epileptogenic effects of 2-BFI and BU224 in miceSignificance of the imidazoline receptors in toxicology.Opioid adjuvant strategy: improving opioid effectiveness.Nanocarriers as treatment modalities for hypertension.Imidazoline I2 receptors: An update.A Comparative Study of Chromatographic Behavior and Lipophilicity of Selected Imidazoline Derivatives.Urinary Bladder Relaxation through Activation of Imidazoline Receptors Induced by Agmatine is Increased in Diabetic Rats.Agmatine Induces Rat Prostate Relaxation through Activation of Peripheral Imidazoline I2 -Receptors.Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice.Imidazoleacetic acid-ribotide in vestibulo-sympathetic pathway neurons.Distribution and cellular localization of imidazoleacetic acid-ribotide, an endogenous ligand at imidazol(in)e and adrenergic receptors, in rat brain.Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptorsCombined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid AddictionChronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain.Acute poisoning with moxonidine? A case report.Relationship between central behavioral effects and peripheral sympathetic neurotransmission functionality during acute cocaine withdrawal syndrome in adult rats.Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice.Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats.The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor.Quantitative structure-mobility relationship analysis of imidazoline receptor ligands in CDs-mediated CE.N-(Imidazolidin-2-ylidene)-1-arylmethanamine Oxides: Synthesis, Structure and Pharmacological Evaluation
P2860
Q21090747-7C095058-711C-4C2B-B162-911911D71A6AQ24654140-169D1960-0582-406F-A531-261902CCAAB6Q26800038-02149D0D-1CC6-4EE6-B1CD-57DE25B50887Q33499502-1A5BF5D0-6B22-4387-BCFE-68709E3B00A2Q34266904-1B67D97D-841A-4CE9-B1FD-B07F06C79C4FQ34781103-82F3EA03-7BDC-4FB2-83D5-10AF981C7F66Q35813129-6AEB3656-0C82-43B4-854A-188E452C78D8Q36084704-13DC718B-4BD5-48CE-A16F-73A6D3213699Q36110606-82095095-AD2B-4E9D-B61F-A5093DB53961Q36148436-13A05F12-DE3F-46B1-BC24-2FA674F53DB0Q36234711-791E4945-2DC1-466D-979B-A0152E1DEA01Q36395524-2334761C-7DFD-4C4D-AF96-503365B85C6EQ36765421-DB8BF99B-DDA1-4E91-9B7B-45393FC2628FQ37303039-24E1E205-F49B-4C68-A06E-77BB8B0D7B96Q38199190-12C1FB41-F235-4FE9-852A-FADCCE7BE16CQ38742586-216DBC42-539E-4709-A04C-5C36ABD656F2Q38760963-976265B8-1B67-44B6-A05F-E9E45342E07BQ39189902-930D0635-939E-4098-ADCB-90B6304ED739Q39608911-471B4529-73DB-4734-B8B2-4F253C8EB76AQ40215578-09FAC609-83BB-4E25-9011-3CDA88F5A14FQ40216091-C440ADFB-793A-4E6D-BAB2-AA19974DFBBCQ41573731-D1011BB3-8BAC-4CD2-AD2F-C3F839D75C36Q41641431-66772F22-FB0A-4676-80E9-E3729A70380DQ41779130-C6C353F1-5103-4516-AB36-1D826A73431CQ41980480-470F4987-AE24-441E-A692-FC4B19718E97Q42382680-8065CCDE-262E-41EA-A587-B179A09FE69AQ45851009-218AC422-6EAD-454E-875F-F470A570F7CFQ46397259-06E97700-FB2B-474F-A867-16B3D6852801Q47626317-221528C8-749A-4877-93C3-236EBFB15855Q51052755-8A32339D-249A-4048-82EB-B6C1C3D46B35Q51060602-74C94C66-0C04-4258-8B27-9394D9876A6AQ51444482-EA91DB35-1C9E-4AEE-A37D-356B299DDAB2Q51599593-A01FB84B-4546-4430-8641-A03B3065F5E5Q58834260-024E5EC6-72F5-4F2A-87F0-B237401AB03D
P2860
Imidazoline receptors, novel agents and therapeutic potential.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Imidazoline receptors, novel agents and therapeutic potential.
@ast
Imidazoline receptors, novel agents and therapeutic potential.
@en
Imidazoline receptors, novel agents and therapeutic potential.
@nl
type
label
Imidazoline receptors, novel agents and therapeutic potential.
@ast
Imidazoline receptors, novel agents and therapeutic potential.
@en
Imidazoline receptors, novel agents and therapeutic potential.
@nl
prefLabel
Imidazoline receptors, novel agents and therapeutic potential.
@ast
Imidazoline receptors, novel agents and therapeutic potential.
@en
Imidazoline receptors, novel agents and therapeutic potential.
@nl
P1476
Imidazoline receptors, novel agents and therapeutic potential.
@en
P2093
P356
10.2174/187152506775268758
P577
2006-01-01T00:00:00Z